Brillant Blue Versus Indocyanine Green for Macular Hole Surgery

Not Applicable

Completed

• Conditions: Idiopathic Macular Holes
• Interventions: Procedure: Indocyanine Green; Procedure: Brillant Blue

• Registration Number: NCT00757471
• Lead Sponsor: The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

Brief Summary

Macular Hole Surgery with two different Dyes

Detailed Description

Not available

Study Timeline

• Study Start: 2008-08
• Study First Submitted: 2008-09-21
• Study First Submitted QC: 2008-09-22
• Study First Posted: 2008-09-23
• Primary Completion: 2015-08
• Study Completion: 2015-08
• Status Verified: 2016-01
• Last Update Submitted: 2016-01-24
• Last Update Posted: 2016-01-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Idiopathic stage 3 and 4 macular holes
• Stage 2 macular holes, followed up for at least 6 months
• Pseudophakic and phakic eyes
• Age over 60 years

Exclusion Criteria

• Traumatic macular holes
• Secondary macular holes
• Severe ocular diseases

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group 2	Indocyanine Green	Indocyanine Green
Group 1	Brillant Blue	Brillant Blue

Primary Outcome Measures

Name	Time	Method
Macular Hole Closure Rate	12 Months

Secondary Outcome Measures

Name	Time	Method
Visual Acuity Microperimetry Optical Coherence Tomography	12 Months

Trial Locations

Locations (1)

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser surgery; 🇦🇹 Vienna, Austria